4 Healthcare Stock Stories Prescribed for Investors on Tuesday

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Vivus (NASDAQ:VVUS) Closing price $10.63

On Tuesday, Vivus reported that it entered into a $110 million non-equity financing with an investment fund managed by Pharmakon Advisors. Through the terms, the firm will make an initial draw of $50 million and will have the option to draw a further $60 million at any time before December 31, 2013. Vivus will make no payments for the first year, and repayments will commence in the second quarter of 2014 and end in the second quarter of 2018, and will be based on scheduled quarterly amounts.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

VVUS

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business